Reports

Impact of breast cancer generics in Europe

Home/Reports | Posted 25/03/2016

Breast cancer generics can increase patient adherence and reduce healthcare budgets for European countries, according to a report by the Germany-based Institute for Healthcare and Social Research (IGES).

Impact of hypertension generics in Europe

Home/Reports | Posted 04/03/2016

A report by the Germany-based Institute for Healthcare and Social Research (IGES) released in November 2015 found that generics of drugs to treat high blood pressure can increase patient adherence and reduce healthcare budgets for European countries.

Impact of generics on European budgets

Home/Reports | Posted 12/02/2016

A report by the Germany-based Institute for Healthcare and Social Research (IGES) released on 16 November 2015 found that generics could contribute to reducing healthcare budgets for European countries.

Generics market share in Europe

Home/Reports | Posted 22/01/2016

Generics make a major contribution to the European drug supply, according to a report by the by Germany-based Institute for Healthcare and Social Research (IGES).

Generics reduce costs and increase access

Home/Reports | Posted 08/01/2016

Generics reduce costs for both patients and payers and increase patient’s access to medicines, according to a report by the Germany-based Institute for Healthcare and Social Research (IGES).

Generics savings continue to climb in the US

Home/Reports | Posted 04/12/2015

Generics manufacturers have joined to celebrate the latest data from the Generic Drug Savings in the US report. According to the report, the US healthcare system saved a record US$254 billion in 2014 from generics, or US$1.68 trillion between 2005 and 2014.